TopicPharmaceutical

Topic: pharmaceutical

India banks on Hyderabad’s ‘Pharma City’ to break China’s stranglehold over drug supplies

Chris Kay - 12 April, 2022

India’s $42 billion drug manufacturing industry relies intensely on China, which supplies almost 70% of the active pharmaceutical ingredients that go into making medicines.

Western companies should supply essential medicines to Ukraine, not pull out entirely

Alex Polyakov - 3 April, 2022

Putin may not be swayed by the suffering of people. Any interruption of supply of medicines can create human misery without any gain.

Pandemic can’t be allowed to devastate nations because of sophisticated, one-sided WTO rules

Seema Sirohi - 8 May, 2021

For President Joe Biden to take a stand against pharmaceutical companies is no small matter. His presidential campaign was the near sole beneficiary of pharma largesse in 2020.

Antidepressant Escitalopram ‘linked to suicidal thoughts’, must carry strongest warning — govt

Himani Chandna - 12 February, 2021

Citing FDA warning, India's drug regulator starts examining warnings, prescribing information and package inserts given by Indian drugmakers manufacturing Escitalopram.

J&J’s new flu drug flop shows how difficult it is to fight viruses

Michelle Fay Cortez - 3 September, 2020

Johnson & Johnson stopped developing the drug pimodivir in the final stage of testing it for patients with influenza A, the most common cause of flu, after a study indicated it won't work.

How a Chinese firm jumped to the front of the global Covid vaccine race

Natalie Obiko Pearson - 2 July, 2020

China’s pharma industry has been dogged by safety incidents & quality scandals. But in recent years, hundreds of Chinese scientists trained in the West have come home.

Cheers to health! This was a decade of drug breakthroughs – from Cancer to Hepatitis C

Max Nisen - 25 December, 2019

Multiple new categories of medicines have moved from dreams & lab benches into the market and people’s lives. Now they need to become affordable.

Indian-born pharma tycoon John Kapoor faces 15 years in jail for America’s opioid crisis

Janelle Lawrence - 19 December, 2019

John Kapoor is accused of leading a racketeering conspiracy that helped fuel US opioid crisis with bribes to boost prescriptions of a highly addictive painkiller.

Hundreds of colleges came up amid India’s pharma boom. Here’s why govt wants no more

Kritika Sharma - 12 November, 2019

India has barred new pharma colleges until 2021-22 to check poor-quality institutes looking to tap the industry’s growing popularity.

New book warns Americans against ‘flea-market quality’ Indian generic drugs

Himani Chandna - 16 May, 2019

Bottle of Lies by journalist Katherine Eban accuses Indian pharma firms of fudging data on quality control and toxic impurities, among other major lapses.

12 Page 1 of 2

On Camera

YourTurn

Guidelines for YourTurn submissions

ThePrint Team - 28 May, 2021

Opinion

Hard-nosed, practical—why India has revived relations with Kabul, and why Taliban is welcoming

Jyoti Malhotra - 28 June, 2022

By protecting the Indian embassy in Kabul for the last ten months, the Taliban is sending a message to its neighbours and the rest of the world.

India readying Bharat NCAP for safer cars but curbing violations can make big difference too

28 June, 2022

Simranjit Singh Mann is reborn because there’s an uneasy vacuum in Punjab

28 June, 2022

Economy

Central banks in Asia spend billions to bolster weakening currencies against rising US dollar

Karl Lester M. Yap - 28 June, 2022

Learning from the 1997 Asian financial crisis, central banks have been accumulating dollars to help defend their currencies during periods of wild market swings.

Topic: pharmaceutical

On Camera

YourTurn

Guidelines for YourTurn submissions

Opinion

Hard-nosed, practical—why India has revived relations with Kabul, and why Taliban is welcoming

India readying Bharat NCAP for safer cars but curbing violations can make big difference too

Simranjit Singh Mann is reborn because there’s an uneasy vacuum in Punjab

Economy

Central banks in Asia spend billions to bolster weakening currencies against rising US dollar

Defence

Almost 4,000 enrol for IAF’s Agnipath recruitment scheme on day 1 of online registrations

National Interest

With Agnipath, Modi govt’s shock & awe doctrine may have misfired a vital reform, yet again

Follow us